,X,FilingDate,TradeDate,Ticker,InsiderName,Title,TradeType,Price,Qty,Owned,delta_Own,Value,1d,1w,1m,6m,ticker
0,M,2022-03-11 16:53:01,2022-03-09,GBIO,Nicholson Donald William,Dir,P - Purchase,473.0,10419,113576,+10%,49257.0,,,,,GBIO
1,M,2021-09-29 19:16:33,2021-09-27,GBIO,Rhodes Jason P,Dir,S - Sale,2540.0,-81088,8279484,-1%,-2059519.0,,,,,GBIO
2,M,2021-09-29 19:15:51,2021-09-27,GBIO,"Atlas Venture Associates X, L.P.",10%,S - Sale,2540.0,-81088,8279484,-1%,-2059519.0,,,,,GBIO
3,M,2021-09-24 21:02:28,2021-09-22,GBIO,Rhodes Jason P,Dir,S - Sale,2602.0,-134998,8279633,-2%,-3511993.0,,,,,GBIO
4,M,2021-09-24 20:59:53,2021-09-22,GBIO,"Atlas Venture Associates X, L.P.",10%,S - Sale,2602.0,-134998,8360572,-2%,-3511993.0,,,,,GBIO
5,D,2021-09-16 16:12:39,2021-09-14,GBIO,Stanton Matthew,CHIEF SCIENTIFIC OFFICER,S - Sale+OE,2807.0,-4500,198154,-2%,-126315.0,,,,,GBIO
6,D,2021-09-14 16:02:11,2021-09-10,GBIO,Stanton Matthew,CHIEF SCIENTIFIC OFFICER,S - Sale+OE,2597.0,-3000,198154,-1%,-77910.0,,,,,GBIO
7,D,2021-08-25 16:05:46,2021-08-23,GBIO,Stanton Matthew,CHIEF SCIENTIFIC OFFICER,S - Sale+OE,2504.0,-1500,198154,-1%,-37560.0,,,,,GBIO
8,D,2021-08-11 16:20:52,2021-08-10,GBIO,Stanton Matthew,CHIEF SCIENTIFIC OFFICER,S - Sale+OE,2263.0,-1500,198154,-1%,-33943.0,,,,,GBIO
9,D,2021-07-14 16:02:58,2021-07-12,GBIO,Stanton Matthew,CHIEF SCIENTIFIC OFFICER,S - Sale+OE,2503.0,-3000,198154,-1%,-75087.0,,,,,GBIO
10,D,2021-07-12 16:02:22,2021-07-08,GBIO,Kerr Douglas,CHIEF MEDICAL OFFICER,S - Sale+OE,2520.0,-3518,326558,-1%,-88670.0,,,,,GBIO
11,,2021-06-28 16:57:05,2021-06-24,GBIO,Rhodes Jason P,Dir,S - Sale,2585.0,-31008,9379484,0%,-801618.0,,,,,GBIO
12,,2021-06-28 16:56:16,2021-06-24,GBIO,"Atlas Venture Associates X, L.P.",10%,S - Sale,2585.0,-31008,608,-98%,-801618.0,,,,,GBIO
13,M,2021-06-23 20:27:58,2021-06-21,GBIO,Rhodes Jason P,Dir,S - Sale,2505.0,-185078,9379542,-2%,-4635967.0,,,,,GBIO
14,M,2021-06-23 20:26:27,2021-06-21,GBIO,"Atlas Venture Associates X, L.P.",10%,S - Sale,2505.0,-185078,31616,-85%,-4635967.0,,,,,GBIO
15,D,2021-06-17 16:05:10,2021-06-15,GBIO,Stanton Matthew,CHIEF SCIENTIFIC OFFICER,S - Sale+OE,2808.0,-1500,198154,-1%,-42120.0,,,,,GBIO
16,D,2021-06-11 16:12:36,2021-06-10,GBIO,Stanton Matthew,CHIEF SCIENTIFIC OFFICER,S - Sale+OE,2723.0,-6000,198154,-3%,-163380.0,,,,,GBIO
17,D,2021-05-28 16:05:31,2021-05-27,GBIO,Stanton Matthew,CHIEF SCIENTIFIC OFFICER,S - Sale+OE,3405.0,-1500,198154,-1%,-51075.0,,,,,GBIO
18,DM,2021-05-12 16:05:33,2021-05-10,GBIO,Stanton Matthew,CHIEF SCIENTIFIC OFFICER,S - Sale+OE,3061.0,-9000,198154,-4%,-275534.0,,,,,GBIO
19,D,2021-05-05 16:10:26,2021-05-03,GBIO,Zimmermann Tracy,CHIEF DEVELOPMENT OFFICER,S - Sale+OE,3570.0,-2500,0,-100%,-89238.0,,,,,GBIO
20,,2021-05-05 16:10:20,2021-05-03,GBIO,McDonough Geoff,"Pres, CEO",S - Sale,3563.0,-10000,1675542,-1%,-356335.0,,,,,GBIO
21,,2021-04-27 16:02:04,2021-04-23,GBIO,McDonough Geoff,"Pres, CEO",S - Sale,3510.0,-10000,1685542,-1%,-351000.0,,,,,GBIO
22,D,2021-04-23 16:05:25,2021-04-22,GBIO,Zimmermann Tracy,CHIEF DEVELOPMENT OFFICER,S - Sale+OE,3332.0,-2500,0,-100%,-83300.0,,,,,GBIO
23,DM,2021-04-23 16:05:20,2021-04-21,GBIO,Stanton Matthew,CHIEF SCIENTIFIC OFFICER,S - Sale+OE,3255.0,-3000,198154,-1%,-97650.0,,,,,GBIO
24,D,2021-04-20 16:05:21,2021-04-16,GBIO,Stanton Matthew,CHIEF SCIENTIFIC OFFICER,S - Sale+OE,2803.0,-1500,198154,-1%,-42045.0,,,,,GBIO
25,M,2021-04-14 20:20:18,2021-04-12,GBIO,Rhodes Jason P,Dir,S - Sale,2592.0,-140682,10479484,-1%,-3646968.0,,,,,GBIO
26,M,2021-04-14 20:19:04,2021-04-12,GBIO,"Atlas Venture Associates X, L.P.",10%,S - Sale,2592.0,-140682,9111939,-2%,-3646968.0,,,,,GBIO
27,D,2021-04-14 16:01:38,2021-04-12,GBIO,Stanton Matthew,CHIEF SCIENTIFIC OFFICER,S - Sale+OE,2624.0,-6000,198154,-3%,-157446.0,,,,,GBIO
28,M,2021-04-09 20:54:17,2021-04-07,GBIO,"Atlas Venture Associates X, L.P.",10%,S - Sale,2820.0,-127095,9252621,-1%,-3583860.0,,,,,GBIO
29,M,2021-04-09 20:53:21,2021-04-07,GBIO,Rhodes Jason P,Dir,S - Sale,2820.0,-127095,10620166,-1%,-3583860.0,,,,,GBIO
30,D,2021-04-07 16:05:24,2021-04-05,GBIO,Kerr Douglas,CHIEF MEDICAL OFFICER,S - Sale+OE,3009.0,-14072,326558,-4%,-423451.0,,,,,GBIO
31,D,2021-03-12 16:03:12,2021-03-10,GBIO,Stanton Matthew,CHIEF SCIENTIFIC OFFICER,S - Sale+OE,3497.0,-10500,198154,-5%,-367210.0,,,,,GBIO
32,D,2021-03-09 16:05:24,2021-03-05,GBIO,Kerr Douglas,CHIEF MEDICAL OFFICER,S - Sale+OE,3144.0,-11267,326558,-3%,-354267.0,,,,,GBIO
33,D,2021-03-05 16:05:45,2021-03-03,GBIO,Zimmermann Tracy,CHIEF DEVELOPMENT OFFICER,S - Sale+OE,4138.0,-3000,0,-100%,-124140.0,,,,,GBIO
34,,2021-03-03 16:10:35,2021-03-01,GBIO,McDonough Geoff,"Pres, CEO",S - Sale,3758.0,-10000,1695542,-1%,-375801.0,,,,,GBIO
35,D,2021-03-03 16:10:25,2021-03-01,GBIO,Zimmermann Tracy,CHIEF DEVELOPMENT OFFICER,S - Sale+OE,3884.0,-2500,0,-100%,-97099.0,,,,,GBIO
36,D,2021-02-12 16:05:19,2021-02-10,GBIO,Stanton Matthew,CHIEF SCIENTIFIC OFFICER,S - Sale+OE,3460.0,-10400,198154,-5%,-359856.0,,,,,GBIO
37,D,2021-02-10 16:05:26,2021-02-08,GBIO,Kerr Douglas,CHIEF MEDICAL OFFICER,S - Sale+OE,3337.0,-11267,326558,-3%,-375954.0,,,,,GBIO
38,D,2021-02-04 16:05:13,2021-02-02,GBIO,Zimmermann Tracy,CHIEF DEVELOPMENT OFFICER,S - Sale+OE,3305.0,-2500,0,-100%,-82625.0,,,,,GBIO
39,D,2021-01-20 16:05:16,2021-01-15,GBIO,Angelino Mark D.,COO,S - Sale+OE,3297.0,-7500,515483,-1%,-247273.0,,,,,GBIO
40,D,2021-01-15 16:06:22,2021-01-14,GBIO,Zimmermann Tracy,CHIEF DEVELOPMENT OFFICER,S - Sale+OE,3309.0,-2500,0,-100%,-82725.0,,,,,GBIO
41,D,2021-01-15 16:05:43,2021-01-14,GBIO,Stanton Matthew,CHIEF SCIENTIFIC OFFICER,S - Sale+OE,3254.0,-5630,198154,-3%,-183212.0,,,,,GBIO
42,D,2021-01-13 16:07:01,2021-01-11,GBIO,Kerr Douglas,CHIEF MEDICAL OFFICER,S - Sale+OE,2758.0,-11267,326558,-3%,-310768.0,,,,,GBIO
43,D,2021-01-13 16:06:22,2021-01-11,GBIO,Stanton Matthew,CHIEF SCIENTIFIC OFFICER,S - Sale+OE,2769.0,-14820,198154,-7%,-410372.0,,,,,GBIO
44,,2021-01-13 16:05:18,2021-01-11,GBIO,Nicholson Donald William,Dir,P - Purchase,2450.0,4081,103157,+4%,99985.0,,,,,GBIO
45,,2021-01-13 16:04:36,2021-01-11,GBIO,Rowland Charles A Jr,Dir,P - Purchase,2450.0,20408,101035,+25%,499996.0,,,,,GBIO
46,D,2020-12-17 16:05:11,2020-12-15,GBIO,Angelino Mark D.,COO,S - Sale+OE,3498.0,-5301,515483,-1%,-185431.0,,,,,GBIO
47,D,2020-12-14 16:05:11,2020-12-10,GBIO,Stanton Matthew,Chief Scientific Officer,S - Sale+OE,3762.0,-10540,198154,-5%,-396499.0,,,,,GBIO
48,D,2020-06-18 18:02:24,2020-06-16,GBIO,Wellington Biomedical Innovation Master Investors (Cayman) I L.P.,10%,P - Purchase,1900.0,1100000,2112546,+109%,20900000.0,,,,,GBIO
49,D,2020-06-18 18:01:41,2020-06-16,GBIO,"Invus Public Equities, L.P.",10%,P - Purchase,1900.0,800000,2814191,+40%,15200000.0,,,,,GBIO
50,D,2020-06-18 17:30:16,2020-06-16,GBIO,Rowland Charles A Jr,Dir,P - Purchase,1900.0,30000,80627,+59%,570000.0,,,,,GBIO
51,D,2020-06-18 17:29:31,2020-06-16,GBIO,"Casdin Capital, LLC",10%,P - Purchase,1900.0,650000,1611215,+68%,12350000.0,,,,,GBIO
52,D,2020-06-17 17:00:06,2020-06-16,GBIO,"Zone Healthcare Holdings, LLC","Member of Group Owning 10%, 10%",P - Purchase,1900.0,400000,5356457,+8%,7600000.0,,,,,GBIO
53,D,2020-06-17 16:59:49,2020-06-16,GBIO,Seybold William,"Member of Group Owning 10%, 10%",P - Purchase,1900.0,400000,5356457,+8%,7600000.0,,,,,GBIO
54,D,2020-06-16 14:50:41,2020-06-16,GBIO,Flynn James E,"Possible Member of 10% Group, 10%",P - Purchase,1900.0,225000,1186215,+23%,4275000.0,,,,,GBIO
